TearLab is pioneering the future of tear film diagnostics to elevate patient care. Using its first of a kind point-of-care ophthalmic in vitro diagnostic platform, TearLab allows you to add data to your insights to guide the diagnosis and management of the ocular surface. With precise and predictive information available in a matter of seconds, you are able to evaluate tear film health, uncover abnormal osmolarity, inform your treatment plan based on severity, and manage patient progress. The TearLab osmolarity test is CLIA waived and has a specific CPT reimbursement code.